GGrantIndex
← Leaderboards

Forcyte Biotechnologies, Inc.

Los Angeles, CA

Compare ↔
$3,185,607
Total funding
6
Grants

Funding over time

peak $876.7K · FY201822
$1M$750K$500K$250K$0
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$3,185,607 · 6

By mechanism

R44$1,703,531 · 1
R43$1,132,076 · 4
R41$350,000 · 1

Investigators at Forcyte Biotechnologies, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

All-Time

Most funded here, all years

Largest grants

Functional high-throughput contractility assay suite to develop therapeutics for asthma andhypertension$826,810
R44 · FY2019 · TR
Functional high-throughput contractility assay suite to develop therapeutics for asthma andhypertension$810,473
R44 · FY2020 · TR
Small molecule enhancers of detrusor contraction discovered using a functional cell contractility screen as therapeutic candidates for underactive bladder$352,511
R43 · FY2021 · DK
Smart, integrated well-plates for ultra-high-throughput screening of excitation-contraction coupling in tissues$350,000
R41 · FY2021 · GM
High-throughput screening of uterine smooth muscle contractility towards therapies to prevent pre-term birth$224,997
R43 · FY2018 · HD
Multiplexed single-cell contractility assay to develop therapeutics for asthma and hypertension$224,987
R43 · FY2018 · TR
High-throughput screening of vasoprotectors in the brain using single-cell force mapping towards anti-migraine therapies$224,905
R43 · FY2018 · AT
Functional high-throughput contractility assay suite to develop therapeutics for asthma andhypertension$66,248
R44 · FY2020 · TR
High-throughput screening of vasoprotectors in the brain using single-cell force mapping towards anti-migraine therapies$41,583
R43 · FY2018 · AT
Small molecule enhancers of detrusor contraction discovered using a functional cell contractility screen as therapeutic candidates for underactive bladder$41,550
R43 · FY2022 · DK
High-throughput screening of vasoprotectors in the brain using single-cell force mapping towards anti-migraine therapies$21,543
R43 · FY2019 · AT